前列腺癌放疗多模态成像中基准标记的可见性与伪影
本研究开发了一种盆腔模体,用于评估前列腺癌多模态成像中不同商用基准标记(FM)的可见性与伪影。结果显示所有金标记在容积扫描中可见但伪影最明显,聚合物标记伪影最少但在门静脉图像和侧位kV图像中可见性差。FM的选择应取决于所采用的IGRT策略。
要点
- 金标记在CT和CBCT上伪影最明显,且伪影随标记尺寸增大而增加。
- 聚合物标记在容积扫描中伪影最少,但在门静脉图像上不可见,侧位kV图像可见性差。
- 最小直径的金标记(Gold Anchor)在侧位kV图像上最难识别。
核心结论
- 不同FM的选择取决于所采用的IGRT策略。
- 在前列腺癌最常用的成像模态(CT、CBCT和MRI)中,聚合物标记优于所研究的金标记。
研究设计与样本
- 开发了一种盆腔模体,中心含3D打印中空立方体填充凝胶模拟前列腺,两根平行PVC棒模拟骨盆骨骼。
- 每个立方体填充明胶并按临床相关空间分布放置三种独特FM;评估的FM包括CIVCO Gold Marker、RiverPoint Gold Marker、Gold Anchor线形和球形以及CIVCO聚合物标记。
- 模体使用MRI、CT、CBCT、平面kV配对、ExacTrac、6MV、2.5MV和集成EPID成像进行扫描,并与前列腺癌患者体内扫描比较。
主要发现
- 所有金标记在容积扫描中可见,但在CT和CBCT上伪影最明显,伪影幅度随FM尺寸增大而增加。
- 聚合物FM在容积扫描中伪影最少,但在门静脉图像上不可见,在侧位kV图像上可见性差。
- 最小直径的金标记(Gold Anchor)在侧位kV图像上最难识别。
临床怎么用
- 选择FM时应考虑所采用的IGRT策略。
- 若以CT、CBCT和MRI为主要成像模态,聚合物标记可能优于金标记。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, a novel pelvic phantom was developed and used to assess the visibility and presence of artefacts from different types of commercial fiducial markers (FMs) on multi-modality imaging relevant to prostate cancer. METHODS AND MATERIALS: The phantom was designed with 3D printed hollow cubes in the centre. These cubes were filled with gel to mimic the prostate gland and two parallel PVC rods were used to mimic bones in the pelvic region. Each cube was filled with gelatine and three unique FMs were positioned with a clinically-relevant spatial distribution. The FMs investigated were; Gold Marker (GM) CIVCO, GM RiverPoint, GM Gold Anchor (GA) line and ball shape, and polymer marker (PM) from CIVCO. The phantom was scanned using several imaging modalities typically used to image prostate cancer patients; MRI, CT, CBCT, planar kV-pair, ExacTrac, 6MV, 2.5MV and integrated EPID imaging. The visibility of the markers and any observed artefacts in the phantom were compared to in-vivo scans of prostate cancer patients with FMs. RESULTS: All GMs were visible in volumetric scans, however, they also had the most visible artefacts on CT and CBCT scans, with the magnitude of artefacts increasing with FM size. PM FMs had the least visible artefacts in volumetric scans but they were not visible on portal images and had poor visibility on lateral kV images. The smallest diameter GMs (GA) were the most difficult GMs to identify on lateral kV images. CONCLUSION: The choice between different FMs is also dependent on the adopted IGRT strategy. PM was found to be superior to investigated gold markers in the most commonly used modalities in the management of prostate cancer; CT, CBCT and MRI imaging.
引用
- Osman SOS, Russell E, King RB, et al. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging. Radiat Oncol. 2019. PMID: 31878967. doi:10.1186/s13014-019-1447-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。